Investment Analysts’ Downgrades for February 11th (ATRC, BP, HRMY, IBP, MAT, NCLH, QCOM, SPOT, TIGO, TREX)
Investment Analysts’ downgrades for Wednesday, February 11th: AtriCure (NASDAQ:ATRC) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. JPMorgan Chase & Co. currently has $36.00 target price on the stock. BP (NYSE:BP) was downgraded by analysts at Melius Research from a buy rating to a sell rating. [...]